All persons or entities that purchased or otherwise acquired the common stock of Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) from February 14, 2020 through August 10, 2020, inclusive.
Final Approval
February 13, 2020 - November 06, 2020
December 15, 2022
November 23, 2022
Gilardi & Co. LLC
Inovio Securities Litigation
Claims Administrator
c/o Gilardi & Co. LLC
P.O. Box 6162
Novato, CA 94948-6162
+1 866-809-3338
info@InovioSecuritiesLitigation.com
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.